TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 11/27/25

2025-11-27 07:20:44 ET Introduction As the year comes to an end, we must be thankful for the therapies that are in late clinical stages. Most importantly, patients are set to benefit immensely. But nearly every trial candidate has implications beyond just patients. The approval of a...

2025-11-24 12:10:15 ET More on pharmaceuticals XPH: Small-Cap Pharma Turns Higher, At Long Last PPH: The Big Pharma ETF President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio Short bets on S&P 500 Healthcare sector rises to 2.00% in...

2025-11-21 16:03:13 ET In my article from October, "My Top 5 Biotech Stocks Big Pharma Could Buy Next," I mentioned how Phathom Pharmaceutical's ( PHAT ) Voquezna and Voquezna Triple Pak is actively capturing share in the U.S. GERD and H. pylori infection treatment markets. ... ...

2025-11-21 11:02:36 ET More on Takeda Pharmaceutical Takeda Pharmaceutical Company Limited (TAK) Q2 FY2025 Earnings Call Transcript Takeda Pharmaceutical Company Limited FY2025 Q2 - Results - Earnings Call Presentation Takeda Pharmaceutical Company Limited (TAK) Disc...

2025-11-21 08:00:50 ET Introduction Bristol-Myers Squibb ( BMY ) is a company that was blessed with multiple early mega blockbuster therapies: Eliquis, Opdivo, and Revlimid (via Celgene). Sometimes, mega blockbusters are more of a curse than a blessing. They lead to tremendo...

2025-11-14 11:50:32 ET Not only has biotech M&A activity picked up recently, but we now have at least two potentially contentious transactions in the space. Following Novo Nordisk A/S's ( NVO ) decision to fight Pfizer Inc. ( PFE ) for obesity drug developer Metsera, Inc. ( MT...

2025-11-14 10:38:47 ET Thesis Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed...

− Phase 1b, Open-Label Study Follow Up Shows Stable Kidney Function (eGFR) in Patients Treated with Investigational Mezagitamab Through Week 96 – 18 Months After Last Dose 1 − Rapid Reductions in Proteinuria and Serum Gd-IgA1 Levels Were Sustained Through Week...

2025-11-06 09:54:16 ET More on Novavax Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript Novavax GAAP EPS of -$1.25 misses by $0.33, revenue of $70.45M ...

Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the Only Approved for Use Regardless of Prior Disease Exposure Takeda is Expanding Global Access to QDENGA in Partnership ...